日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Successful Therapy over 12 Months of People with Cystic Fibrosis with Rare Non-phe508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations with Elexacaftor/Tezacaftor/Ivacaftor (ETI)

使用 Elexacaftor/Tezacaftor/Ivacaftor (ETI) 治疗 12 个月,成功治愈了患有罕见非 Phe508del 囊性纤维化跨膜传导调节因子 (CFTR) 突变的囊性纤维化患者。

Sütering, Tomke; Bode, Sebastian F N; Fischer, Rainald; Fabricius, Dorit